Pharming Group NV News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

16.05.19	Pharming Group Reports Interim Financial Results for the First Quarter of 2019 (PR Newswire)
15.05.19	Ausblick: Pharming Group NV zieht Bilanz zum jüngsten Jahresviertel (finanzen.net)
10.04.19	Pharming Group Announces Notice to Convene to Annual General Meeting of Shareholders (PR Newswire)
29.03.19	Pharming Group Announces Publication of Its Annual Report 2018 and a Provisional Commitment to Invest in Supplier (PR Newswire)
07.03.19	Pharming Group Reports Strong Preliminary Financial Results for 2018 Including First Year of Net Profit (PR Newswire)
06.03.19	Ausblick: Pharming Group NV stellt Zahlen zum jüngsten Quartal vor (finanzen.net)
25.02.19	Pharming Announces Abstract Presented at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting and Sponsorship of the AAAAI Foundation Michael M. Frank, MD, FAAAI Lectureship (PR Newswire)
23.01.19	Pharming Announces Abstracts Presented at The Western Society of Allergy, Asthma & Immunology (WSAAI) Conference This Week (PR Newswire)
07.12.18	Pharming Reports Favourable Conclusion from First Investigator-initiated Direct Comparative Real-world Study of Acute Hereditary Angioedema Therapies (PR Newswire)
25.10.18	Pharming Group Reports Interim Financial Results for the First Nine Months of 2018 (PR Newswire)
24.10.18	Ausblick: Pharming Group NV veröffentlicht Zahlen zum vergangenen Quartal (finanzen.net)
17.10.18	Pharming Reports Positive Data From First Investigator-initiated Study of rhC1-Inhibitor (RUCONEST®) in Contrast-induced Nephropathy (PR Newswire)
19.09.18	Pharming Receives Complete Response Letter from FDA (PR Newswire)
30.07.18	Pharming Announces Further Issue of Shares as Employee Options Are Exercised (PR Newswire)
26.07.18	Pharming Reports on Financial Results for the First Half of 2018 (PR Newswire)
21.12.16	Original-Research: PHARMING (von First Berlin Equity Research GmbH): BUY (dpa-afx)
28.10.16	Original-Research: PHARMING (von First Berlin Equity Research GmbH): BUY (dpa-afx)
07.10.16	Original-Research: PHARMING (von First Berlin Equity Research GmbH): BUY (dpa-afx)
30.08.16	Original-Research: PHARMING (von First Berlin Equity Research GmbH): BUY (dpa-afx)
29.07.16	Original-Research: PHARMING (von First Berlin Equity Research GmbH): BUY (dpa-afx)
20.05.16	Original-Research: PHARMING (von First Berlin Equity Research GmbH): BUY (dpa-afx)
06.03.14	Pharming Reports On Preliminary Financial Results 2013 (GlobeNewswire)
24.02.14	PHARMING AND SALIX ANNOUNCE EXTENSION OF PDUFA ACTION DATE FOR RUCONEST® (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Pharming Group NV

Aktien Top/Flop

Meistgelesene Nachrichten